Regulation of Monoamine Transporters 17
27. Gainetdinov, R. R., Fumagalli, F., Jones, S. R., and Caron, M G. (1997)
Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence
from mice lacking the transporter. J. Neurochem.69, 1322–1325.
28. Gainetdinov, R. R., Jones, S. R., Fumagalli, F., Wightman, R. M., and Caron,
M. G. (1998) Re-evaluation of the role of the dopamine transporter in dopam-
ine system homeostasis. Brain. Res. Brain Res. Rev.26, 148–153.
29. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G. (1996)
Hyperlocomotion and indifference to cocaine and amphetamine in mice lack-
ing the dopamine transporter. Nature.379, 606–612.
30. Hirata, H. and Cadet, J. L. (1997) Methamphetamine-induced serotonin neu-
rotoxicity is attenuated in p53-knockout mice. Brain Res. 768, 345–348.
31. Jones, S. R., Gainetdinov, R. R., Hu, X. T., Cooper, D. C., Wightman, R. M.,
White, F. G., et al. (1999) Loss of autoreceptor functions in mice lacking the
dopamine transporter. Nat. Neurosci. 2, 649–655.
32. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., and
Caron, M. G. (1998) Profound neuronal plasticity in response to inactivation
of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95, 4029.
33. Jones, S. R., Gainetdinov, R. R., Wightman, R. M., and Caron, M. G. (1998)
Mechanisms of amphetamine action revealed in mice lacking the dopamine
transporter.J. Neurosci. 18, 1979–1986.
34. Rioux, A., Fabre, V., Lesch, K. P., Moessner, R., Murphy, D. L., Lanfumey,
L., et al. (1999) Adaptive changes of serotonin 5-HT2A receptors in mice
lacking the serotonin transporter. Neurosci. Lett.262, 112–116.
35. Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., and Geyer, M. A.
(2001) Prepulse inhibition deficits and perseverative motor patterns in
dopamine transporter knock-out mice: differential effects of D1 and D2
receptor antagonists. J. Neurosci. 21, 305–313.
36. Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller,G. W.,
Caron, M. G., et al. (2001) Hyperactivity and impaired response habituation
in hyperdopaminergic mice. Proc. Natl. Acad. Sci. USA98, 1982–1987.
37. Meltzer, H. Y. and Arora, R. C. (1987) Genetic control of serotonin uptake in
blood platelets: A twin study. Psychiatry Res. 24, 263–269.
38. Owens, M. J., Morgan, W. N., Plott, S. J., and Nemeroff, C. B. (1997) Neu-
rotransmitter receptor and transporter binding profile of antidepressents and
their metabolites. J. Pharmacol. Exp. Ther.283, 1305–1322.
39. Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni,
I., et al. (2000) Orthostatic intolerance and tachycardia associated with nore-
pinephrine-transporter deficiency. N. Engl. J. Med. 342, 541–549.
40. Bonnet-Brilhault, F., Laurent, C., Thibaut, F., Campion, D., Chavand, O.,
Samolyk, D., et al. (1997) Sertonin transporter gene polymorphism and
schizophrenia: an association study. Biol. Psychiatry42, 634–636.
41. Klauck, S. M., Poustka, F., Benner, A., Lesch, K. P., and Poustka, A. (1997)
Serotonin transporter (5-HTT) gene variants associated with autism? Human
Mol. Genet.6, 2233–2238.
42. Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S.,
et al. (1996) Association of anxiety-related traits with a polymorphism in the
serotonin transporter gene regulatory region. Science274, 1527–1531.